Clinical Trial Update: R-CHOP + GM-CSF for Previously Untreated LCL in Elderly [Phase 2]

View source ↗

Summary

Phase 2 trial of R-CHOP plus GM-CSF for elderly patients with previously untreated diffuse large B-cell lymphoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• R-CHOP

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 2 | Status: COMPLETED